天麻素联合倍他司汀治疗椎基底动脉供血不足临床分析  

Clinical analysis of treating vertebrobasilar insufficient blood supply with Tianmasu plus betahistine

作　　者：杨东宁[1] 

机构地区：[1]河南省安阳市第三人民医院,河南安阳455000

出　　处：《中医临床研究》2013年第17期67-68,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:观察天麻素注射液联合盐酸倍他司汀注射液治疗椎基底动脉供血不足引起的眩晕症状,在不同中医证型间的疗效差别。方法:对120例确诊为椎基底动脉供血不足且有眩晕症状的患者,均给予天麻素注射液联合盐酸倍他司汀注射液治疗,按中医辨证分为肝阳上亢组和其它证型组;观察两组患者的治疗效果。结果:肝阳上亢组治愈率明显高于其它证型组,二者相比差异具有显著性(P<0.05)。结论:天麻素注射液适用于肝阳上亢的眩晕症患者,在使用其治疗椎基底动脉供血不足引起的眩晕症状时也要遵循中医辨证论治的原则。Objective： To observe the symptoms of vertigo caused by vertebrobasilar insufficient blood supply with Tianmasu plus betahistine and the effect differences between different syndrome types. Methods： 120 cases were given Tianmasu plus betahistine injection, with Ganyang Shangkang group and other syndrome-type group. To observe the effect of the two groups. Results： The cure rate of the former was higher than the latter group. The difference was significant （P〈0.05）. Conclusion： Tianmasu injection applies to the vertigo of Ganyang Shangkang type, should follow the principles of TCM syndrome differentiation.

关 键 词：眩晕症 天麻素注射液 椎基底动脉供血不足 辨证论治 证型 

分 类 号：R255.3[医药卫生—中医内科学]